The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $12.07

Today's change+0.05 +0.42%
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $12.07

Today's change+0.05 +0.42%
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.

Ehealth Inc up (U.S.)$0.05

Ehealth Inc closed up Wednesday by (U.S.)$0.05 or 0.42% to (U.S.)$12.07. Over the last five days, shares have lost 7.15% and are down 51.57% for the last year to date. This security has underperformed the S&P 500 by 76.73% during the last year.

Key company metrics

  • Open(U.S.) $12.04
  • Previous close(U.S.) $12.02
  • High(U.S.) $12.19
  • Low(U.S.) $11.81
  • Bid / Ask-- / --
  • YTD % change-51.57%
  • Volume180,559
  • Average volume (10-day)479,018
  • Average volume (1-month)329,386
  • Average volume (3-month)288,437
  • 52-week range(U.S.) $8.81 to (U.S.) $39.16
  • Beta1.35
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.96
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.99%Sector:FinancialsIndustry:Insurance - Life & Health
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue61454143
Total other revenue--------
Total revenue61454143
Gross profit59444042
Total cost of revenue2111
Total operating expense63593736
Selling / general / administrative56583635
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)4------
Other operating expenses, total--------
Operating income-2-1446
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-1446
Income after tax-2-1923
Income tax, total0523
Net income-2-1923
Total adjustments to net income--------
Net income before extra. items-2-1923
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-1923
Inc. avail. to common incl. extra. items-2-1923
Diluted net income-2-1923
Dilution adjustment--------
Diluted weighted average shares18181820
Diluted EPS excluding extraordinary itemsvalue per share-0.12-1.080.080.15
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.05-1.080.080.15